Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Publications by year

OPHG Publications

This page shows a list of yearly publications by the CDC Office of Public Health Genomics. For all publications in genomics in various CDC programs, please search our Public Health Genomics Knowledge Base.

Books

1. Khoury MJ, Bedrosian S, Gwinn M, Little J, Ioannidis JP (eds). Human Genome Epidemiology (2nd ed.): Building the evidence for using genetic information to improve health and prevent disease. Oxford University Press, New York, 2010

2. Khoury MJ, Little J., Burke W (eds). Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, New York, 2004

3. Khoury MJ, Burke W, Thompson E (eds). Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. Oxford University Press, New York, 2000

4. Muin J. Khoury, Terri H. Beaty and Bernice H. Cohen. Fundamentals of Genetic Epidemiology. Oxford University Press, New York, 1993

 

OPHG Scientific Publications

Peer-reviewed scientific articles written by staff in CDC’s Office of Public Health Genomics and other researchers and public health professionals. You can perform a search of the CDC-Authored Genomics Publication Database of the Public Health Genomics Knowledge Base for specific topics.

 

2017
  1. Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ. Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014. Genet Med. 2017 Sep 21.
  2. Khoury MJ. No Shortcuts on the Long Road to Evidence-Based Genomic Medicine. JAMA. 2017 Jul 4;318(1):27-28.
  3. Khoury MJ, Galea S. Evaluating Precision Medicine’s Ability to Improve Population Health-Reply. JAMA. 2017 Jan 24;317(4):441.
  4. Knowles JW, Rader DJ, Khoury MJ. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing. JAMA. 2017 Jul 25;318(4):381-382.
  5. Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ. BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas – United States, 2009-2014. MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.
  6. Lu CY, Williams MS, Ginsburg GS, Toh S, Brown JS, Khoury MJ. A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system. Genet Med. 2017 Aug 10.
  7. Lynch JA, Berse B, Bowen MS, Grosse SD. In Reference to: “Cost and Utility of Thrombophilia Testing” J. Hosp. Med. 2017 September;12(9):783.
  8. Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J. Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data. Genet Med. 2017 Aug;19(8):890-899.
  9. Qadir XV, Clyne M, Lam TK, Khoury MJ, Schully SD. Trends in published meta-analyses in cancer research, 2008-2013. Cancer Causes Control. 2017 Jan;28(1):5-12.
  10. Phillips KA, Deverka PA, Sox HC, Khoury MJ, Sandy LG, Ginsburg GS, Tunis SR, Orlando LA, Douglas MP. Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. Genet Med. 2017 Apr 13.
  11. Roberts MC, Kennedy AE, Chambers DA, Khoury MJ. The current state of implementation science in genomic medicine: opportunities for improvement. Genet Med. 2017 Aug;19(8):858-863.

     

    2016
  12. Auffray C, Caulfield T, Griffin JL, Khoury MJ, Lupski JR, Schwab M. From genomic medicine to precision medicine: highlights of 2015. Genome Med. 2016 Jan 29;8(1):12.
  13. Chambers DA, Feero WG, Khoury MJ. Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research. JAMA. 2016 May 10;315(18):1941-2.
  14. Dotson WD, Bowen MS, Kolor K, Khoury MJ. Clinical utility of genetic and genomic services: context matters. Genet Med. 2016 Jul;18(7):672-4.
  15. Grosse SD, Khoury MJ. Epidemiology matters: peering inside the “black box” in economic evaluations of genetic testing. Genet Med. 2016 Oct;18(10):963-5.
  16. Gwinn M, MacCannell DR, Khabbaz RF. Integrating advanced molecular technologies into public health. J Clin Microbiol. 2016 Dec 28. pii: JCM.01967-16.
  17. Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JP. Reproducible Research Practices and Transparency across the Biomedical Literature. PLoS Biol. 2016 Jan 4;14(1):e1002333.
  18. Kennedy AE, Khoury MJ, Ioannidis JP, Brotzman M, Miller A, Lane C, Lai GY, Rogers SD, Harvey C, Elena JW, Seminara D. The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research. Cancer Epidemiol Biomarkers Prev. 2016 Jul 20. pii: cebp.0412.2016.
  19. Khoury MJ, Galea S. Will Precision Medicine Improve Population Health? JAMA. 2016 Oct 4;316(13):1357-1358.
  20. Khoury MJ, Iademarco MF, Riley WT. Precision Public Health for the Era of Precision Medicine. Am J Prev Med. 2016 Mar;50(3):398-401.
  21. Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN. Implementation of the 21-gene recurrence score test in the United States in 2011. Genet Med. 2016 Oct;18(10):982-90.
  22. Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ. Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiol Biomarkers Prev. 2016 Aug 9. pii: cebp.0555.2016.
  23. Rodriguez JL, Thomas CC, Massetti GM, Duquette D, Avner L, Iskander J, Khoury MJ, Richardson LC. CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control. MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1291-1294.
  24. Valdez R, Grosse SD, Khoury MJ. The need for a next-generation public health response to rare diseases. Genet Med. 2016 Oct 27.
  25. Yu W, Gwinn M, Dotson WD, Green RF, Clyne M, Wulf A, Bowen S, Kolor K, Khoury MJ. A knowledge base for tracking the impact of genomics on population health. Genet Med. 2016 Dec;18(12):1312-1314. 9.

     

    2015
  26. Brownson RC, Samet JM, Chavez GF, Davies MM, Galea S, Hiatt RA, Hornung CA, Khoury MJ, Koo D, Mays VM, Remington P, Yarber L. Charting a future for epidemiologic training. Ann Epidemiol. 2015 Jun;25(6):458-65.
  27. Chang CQ, Tingle SR, Filipski KK, Khoury MJ, Lam TK, Schully SD, Ioannidis JP. An overview of recommendations and translational milestones for genomic tests in cancer. Genet Med. 2015 Jun;17(6):431-40.
  28. Green RF, Dotson WD, Bowen S, Kolot K, Khoury MJ. Genomics in Public Health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC) Healthcare 2015, 3(3), 830-837;
  29. Janssens AC, Gwinn M. Erratum to: Novel citation-based search method for scientific literature: application to meta-analyses. BMC Med Res Methodol. 2015 Nov 10;15:97.
  30. Janssens AC, Gwinn M. Novel citation-based search method for scientific literature: application to meta-analyses. BMC Med Res Methodol. 2015 Oct 13;15:84.
  31. Khoury MJ. Planning for the Future of Epidemiology in the Era of Big Data and Precision Medicine. Am J Epidemiol. 2015 Dec 1. pii: kwv228.
  32. Khoury MJ. Public Health Genomics has come of age. Genewatch 28-1 Jan-May 2015
  33. Khoury MJ, Cashion A, Billings PR. Evaluating the Clinical Utility of Genomic Variants Derived from Next-Generation Sequencing for Opportunistic Disease Screening and Risk Assessment: Evidence Gaps and Priorities. Institute of Medicine Discussion Report, February 5, 2015.
  34. Khoury MJ, Evans JP. A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. JAMA. 2015 Jun 2;313(21):2117-8.
  35. Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD. Evolution of the “drivers” of translational cancer epidemiology: Analysis of funded grants and the literature. Am J Epidemiol. 2015 Apr 1;181(7):451-8.
  36. Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD. Lam et al. Respond to “Driving for Further Evolution”. Am J Epidemiol. 2015 Apr 1;181(7):463.
  37. Marrone M, Schilsky RL, Liu G, Khoury MJ, Freedman AN. Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology. Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):484-9.
  38. Marrone M, Stewart A, Dotson WD. Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews. Genet Med. 2015 Jul;17(7):519-32.
  39. Marcus PM, Freedman AN, Khoury MJ. Targeted Cancer Screening in Average-Risk Individuals. Am J Prev Med. 2015 Nov;49(5):765-71.
  40. May T, Strong KA, Khoury MJ, Evans JP. Can targeted genetic testing offer useful health information to adoptees? Genet Med. 2015 Jul;17(7):533-5.
  41. Parkman AA, Foland J, Anderson B, Duquette D, Sobotka H, Lynn M, Nottingham S, Dotson WD, Kolor K, Cox SL .Public awareness of genetic nondiscrimination laws in four States and perceived importance of life insurance protections. J Genet Couns. 2015 Jun.
  42. Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS; ClinGen. ClinGen–the Clinical Genome Resource. N Engl J Med. 2015 Jun 4;372(23):2235-42.
  43. Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012
  44. Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med. 2015 Jan;17(1):63-7.
  45. Spitz MR, Lam TK, Schully SD, Khoury MJ. The authors reply. Am J Epidemiol. 2015 Mar 1;181(5):361.
  46. Wang C, Sen A, Plegue M, Ruffin MT 4th, O’Neill SM, Rubinstein WS, Acheson LS; Family Healthware™ Impact Trial (FHITr) Group; Family Healthware Impact Trial FHITr Group. Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr). Prev Med. 2015 Aug;77:28-34.
     Top of Page

     

    2014
  47. Alfano CM, Smith T, de Moor JS, Glasgow RE, Khoury MJ, Hawkins NA, Stein KD, Rechis R, Parry C, Leach CR, Padgett L, Rowland JH. An action plan for translating cancer survivorship research into care. J Natl Cancer Inst. 2014 Sep 22;106(11). pii: dju287.
  48. Altekruse SF, Rosenfeld GE, Carrick DM, Pressman EJ, Schully SD, Mechanic LE, Cronin KA, Hernandez BY, Lynch CF, Cozen W, Khoury MJ, Penberthy LT. SEER Cancer Registry Biospecimen Research: Yesterday and Tomorrow. Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2681-7.
  49. Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Maria Knoppers B, Khoury MJ, Meslin EM, Van Duijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W. Beyond public health genomics: proposals from an international working group. European Journal of Public Health, August 29, 2014
  50. Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD. A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet. 2014 Mar;22(3):402-8.
  51. Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ. Horizon scanning for translational genomic research beyond bench to bedside. Genet Med. 2014 Jan 9.
  52. Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method. Clin Pharmacol Ther. 2014 Apr;95(4):394-402.
  53. Feero G, Manolio T, Khoury M Translational research is a key to nongeneticist physicians’ genomics education. Genetics in Medicine (2014) 2014 Dec;16(12):871-3.
  54. Gwinn M, Ioannidis JP, Little J, Khoury MJ Editorial: Updated guidance on Human Genome Epidemiology (HuGE) reviews and meta-analyses of genetic associations Am. J. Epidemiol. 2014 Sep 15;180(6):559-61
  55. Hamilton JG1, Edwards HM, Khoury MJ, Taplin SH. Cancer Screening and Genetics: A Tale of Two Paradigms. Cancer Epidemiol Biomarkers Prev. 2014 Apr 4.
  56. Iglesias AI, Mihaescu R, Ioannidis JP, Khoury MJ, Little J, van Duijn CM, Janssens AC. Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement. J Clin Epidemiol. 2014 Jan 7
  57. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014 Jan 11;383(9912):166-75.
  58. Ioannidis JP, Khoury MJ. Assessing Value in Biomedical Research: The PQRST of Appraisal and Reward. JAMA. Aug 6;312(5):483-4.
  59. Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN. Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol. 2014 Jan;25(1):16-23.
  60. Khoury MJ. A Primer Series on -Omic Technologies for the Practice of Epidemiology. Am J Epidemiol. 2014 Jun 24. pii: kwu141.
  61. Khoury MJ, Bowen S. The public health role in translating advances in genomics. Clinical Omics, August 13, 2014
  62. Khoury MJ, Ioannidis JP. Medicine. Big data meets public health. Science. 2014 Nov 28;346(6213):1054-5.
  63. Khoury MJ, Rose S. Q&A: Muin Khoury on cancer epidemiology. Cancer Discov. 2014 Feb;4(2):140.
  64. Knowles JW, O’Brien EC, Greendale K, Wilemon K, Genest J, Sperling LS, Neal WA, Rader DJ, Khoury MJ. Reducing the burden of disease and death from familial hypercholesterolemia: A call to action. Am Heart J. 2014 Dec;168(6):807-11.
  65. Scheuner MT, Hamilton AB, Peredo J, Sale TJ, Austin C, Gilman SC, Bowen MS, Goldzweig CL, Lee M, Mittman BS, Yano EM. A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet Med. 2014 Jan;16(1):60-9.
  66. Schully SD. Khoury MJ. What is translational genomics? An expanded research agenda for improving individual and population health. Applied & Translational Genomics Vol 3 Iss 4 Pg 82-83 Dec 2014
  67. Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ. The Cancer Genomics and Epidemiology Navigator: An NCI Online Tool to Enhance Cancer Epidemiology Research. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2610-1.
  68. Shaikh AR, Butte AJ, Schully SD, Dalton WS, Khoury MJ, Hesse BW. Collaborative biomedicine in the age of big data: the case of cancer. J Med Internet Res. 2014 Apr 7;16(4):e101.
  69. Spitz MR, Lam TK, Schully SD, Khoury MJ. The Next Generation of Large-Scale Epidemiologic Research: Implications for Training Cancer Epidemiologists. Am J Epidemiol. 2014 Sep 18. pii: kwu256.
  70. St Pierre J, Bach J, Duquette D, Oehlke K, Nystrom R, Silvey K, Zlot A, Giles R, Johnson J, Anders HM, Gwinn M, Bowen S, Khoury MJ. Strategies, actions, and outcomes of pilot state programs in public health genomics, 2003-2008. Preventing Chronic Disease 2014;11:130267
  71. Teutsch SM, Fielding JE, Khoury MJ, Evans JP. Utility before business. Genet Med. 2014 Jul 10.
  72. Verma M, Rogers S, Divi RL, Schully SD, Nelson S, Joseph Su L, Ross SA, Pilch S, Winn DM, Khoury MJ. Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):223-33.  Top of Page

     

    2013
  73. Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. 2012 highlights in translational ‘omics. Genome Med. 2013 Jan 31;5(1):10.
  74. Burgio MR Jr, Ioannidis JP, Kaminski BM, Derycke E, Rogers S, Khoury MJ, Seminara D. Collaborative Cancer Epidemiology in the 21st Century: the Model of Cancer Consortia. Cancer Epidemiol Biomarkers Prev. 2013 Sep 19.
  75. Burke W, Matheny Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H, Uhlmann WR, Wilfond B, Wolf SM, Zimmern R. Recommendations for returning genomic incidental findings? We need to talk! Genet Med. 2013 Aug 1.
  76. Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD. A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet. 2013 Jul 24.
  77. Evans JP, Khoury MJ. The arrival of genomic medicine to the clinic is only the beginning of the journey. Genet Med. 2013 Jan 10 doi: 10.1038/gim.2012.133.
  78. Glasgow RE, Doria-Rose VP, Khoury MJ, Elzarrad M, Brown ML, Stange KC. Comparative Effectiveness Research in Cancer: What Has Been Funded and What Knowledge Gaps Remain? J Natl Cancer Inst. 2013 Apr 11.
  79. Hutter CM, Mechanic LE, Chatterjee N, Kraft P, Gillanders EM; NCI Gene-Environment Think Tank. Abnet CC, Amos C, Balshaw D, Bickeböller H, Bierut LJ, Boffetta P, Bondy M, Chanock S, Chatterjee N, Chen HS, Cox N, Divi R, Dupuis J, Ellison G, Fallin MD, Gauderman WJ, Gillanders E, Haiman C, Hutter C, Simonds NI, Iversen E, Khoury MJ, Kraft P, Le Marchand L, Lin D, McAllister K, Mechanic L, Peters U, Prentice R, Rebbeck T, Reedy J, Rothman N, Schully S, Seminara D, Shaughnessy D, Shete S, Spiegelman D, Stram DO, Thomas D, Wang M, Wang W, Weinberg C, Winn DM, Witte JS. Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol. 2013 Nov;37(7):643-57. doi: 10.1002/gepi.21756. Epub 2013 Oct 5.
  80. Ioannidis JP, Chang CQ, Lam TK, Schully SD, Khoury MJ. The geometric increase in meta-analyses from China in the genomic era PLoS One. 2013 Jun 12;8(6):e65602.
  81. Ioannidis JP, Khoury MJ. Are randomized trials obsolete or more important than ever in the genomic era? Genome Med. 2013 Apr 18;5(4):32.
  82. Ioannidis JP, Schully SD, Lam TK, Khoury MJ. Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):3-10.
  83. Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN. Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol. 2013 Dec 4.
  84. Khoury MJ, Janssens AC, Ransohoff DF How can polygenic inheritance be used in population screening for common diseases? Genet Med. 2013 Feb 14.
  85. Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle R, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Zauber AG, Winn DM, Schully SD. Transforming Epidemiology for 21st Century Medicine and Public Health. Cancer Epidemiol Biomarkers Prev. 2013 Mar 5.
  86. Lam TK, Schully SD, Rogers S, Benkeser R, Reid BC Reidbr Mai, Khoury MJ. Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints. Cancer Epidemiol Biomarkers Prev. 2013 Feb 14
  87. Lam TK, Spitz M, Schully SD, Khoury MJ. “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities. Cancer Epidemiol Biomarkers Prev. 2013 Jan 15.
  88. Lynch JA, Khoury MJ, Borzecki A, Cromwell J, Hayman LL, Ponte PR, Miller GA, Lathan CS. Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research. Genet Med. 2013 Feb 28.
  89. Office of Public Health Genomics, Centers for Disease Control and Prevention Can molecular testing indicate optimal treatment in metastatic colorectal cancer? CDC Expert Commentary, Medscape, 2013 Jul 1
  90. Palomaki GE, Melillo S, Marrone M, Douglas MP. Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review. Genet Med. 2013 Aug;15(8):600-11.
  91. Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospect J Natl Cancer Inst. 2013 May 9.
  92. Stewart A. Genetic Testing Strategies in Newly Diagnosed Endometrial Cancer Patients Aimed at Reducing Morbidity or Mortality from Lynch Syndrome in the Index Case or Her Relatives PLoS Currents: Evidence on Genomic Tests 2013 Sep 16
  93. Stewart A. SLCO1B1 polymorphisms and statin-induced myopathy. PLoS Currents: Evidence on Genomic Tests 2013 Dec 4
  94. Verma M, Khoury MJ, Ioannidis JP. Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):189-200.
  95. Verma M, Rogers S, Divi RL, Schully SD, Nelson S, Su LJ, Ross S, Pilch S, Winn DM, Khoury MJ. Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev. 2013 Dec 10
  96. Zhang L, Gwinn M, Hu D. Viral Hepatitis C gets personal – The value of human genomics to public health Public Health Genomics 16(4) 2013  Top of Page

     

    2012
  97. Auffray C, Caulfied T, Khoury M, Lupski J, Schwab M and Veenstr T. Looking back at genomic medicine in 2011 [PDF 274.87 KB]. Genome Medicine 2012, 4:9
  98. Bellcross CA, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, Joseph DA, Kaye C, Lubin I, Meyer LJ, Reyes M, Scheuner MT, Schully SD, Senter L, Stewart SL, St Pierre J, Westman J, Wise P, Yang VW, Khoury MJ. Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: Summary of a public health/clinical collaborative meeting. Genet Med. 2012 Jan;14(1):152-62.
  99. Boffetta P, Winn DM, Ioannidis JP, Thomas DC, Little J, Davey Smith G, Cogliano VJ, Hecht SS, Seminara D, Vineis P, Khoury MJ. Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol. 2012 May 16.
  100. Bowen MS, Kolor K, Dotson WD, Ned RM, Khoury MJ. Public Health Action in Genomics Is Now Needed beyond Newborn Screening. Public Health Genomics. 2012 Sep 11
  101. Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KA, Khoury MJ, Ramsey SD. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med. 2012 Apr 5.
  102. Dorman JS, Valdez R, Liu T, Wang C, Rubinstein WS, O’Neill SM, Acheson LS, Ruffin MT 4th, Khoury MJ. Health beliefs among individuals at increased familial risk for type 2 diabetes: Implications for prevention. Diabetes Res Clin Pract. 2012 Jan 16.
  103. Glasgow RE, Vinson C, Chambers D, Khoury MJ, Kaplan RM, Hunter C. National Institutes of Health Approaches to Dissemination and Implementation Science: Current and Future Directions. Am J Public Health. 2012 May 17.
  104. Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research Genet Med 2012 Apr.
  105. Grimsby JL, Porneala BC, Vassy JL, Yang Q, Florez JC, Dupuis J, Liu T, Yesupriya A, Chang MH, Ned RM, Dowling NF, Khoury MJ, Meigs JB, Magic Investigators T. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet. 2012 Apr 27;13(1):30.
  106. Hayes DF, Khoury MJ, Ransohoff D. Why Hasn’t Genomic Testing Changed the Landscape in Clinical Oncology? ASCO 2012 Educational Book e52-55.
  107. Hesse BW, Arora NK, Khoury MJ. Implications of internet availability of genomic information for public health practice. Public Health Genomics. 2012;15(3-4):201-8.
  108. Janssens AC, Henneman L, Detmar SB, Khoury MJ, Steyerberg EW, Eijkemans MJ, Mushkudiani N, Oostra BA, van Duijn CM, Mackenbach JP. Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol. 2012 Jan;65(1):82-9. Epub 2011 Sep 1.
  109. Khoury MJ, Coates RJ, Fennell ML, Glasgow RE, Scheuner MT, Schully SD, Williams MS, Clauser SB. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr. 2012 ;2012(44):112-20.
  110. Khoury MJ, Freedman AN, Gillanders EM, Harvey CE, Kaefer C, Reid BC, Rogers S, Schully SD, Seminara D, Verma M. Frontiers in Cancer Epidemiology: A Challenge to the Research Community from the Epidemiology and Genomics Research Program at the National Cancer Institute. Cancer Epidemiol Biomarkers Prev. 2012 Jun 4.
  111. Khoury MJ, Gwinn ML, Glasgow RE, Kramer BS. A population approach to precision medicine. Am J Prev Med. 2012 Jun;42(6):639-45.
  112. Khoury MJ, Gwinn M, Dotson WD, Schully SD. Knowledge integration at the center of genomic medicine. Genet Med. 2012 May 3.
  113. Khoury MJ, Gwinn M, Bowen MS, Dotson WD. Beyond Base Pairs to Bedside: A Population Perspective on How Genomics Can Improve Health. Am J Public Health. 2011 Nov 17.
  114. Kolor K, Duquette D, Zlot A, Foland J, Anderson B, Giles R, Wrathall J, Khoury MJ. Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med. 2012 Oct;14(10):860-7.
  115. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, Destefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP; 23andMe, The Genetic Epidemiology of Parkinson’s Disease (GEO-PD) Consortium; The International Parkinson’s Disease Genomics Consortium (IPDGC); The Parkinson’s Disease GWAS Consortium; The Wellcome Trust Case Control Consortium 2 (WTCCC2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson’s Disease Genetics: The PDGene Database. PLoS Genet. 2012 Mar;8(3):e1002548.
  116. McBride CM, Bowen SM, Shully SD, Khoury MJ. Introduction to the 4th National Conference on Genomics and Public Health. Public Health Genomics. 2012;15(3-4):117.
  117. Moonesinghe R, Ioannidis JP, Flanders WD, Yang Q, Truman BI, Khoury MJ. Estimating the contribution of genetic variants to difference in incidence of disease between population groups. Eur J Hum Genet. 2012 Feb 15.
  118. Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, Chang MH, Dowling NF. The ACE I/D Polymorphism in US Adults: Limited Evidence of Association With Hypertension-Related Traits and Sex-Specific Effects by Race/Ethnicity. Am J Hypertens. 2012 Feb;25(2):209-15.
  119. Rowell J, Dowling N, Yu W, Yesupriya A, Zhang L, Gwinn M. Trends in Population-Based Studies of Human Genetics in Infectious Diseases. 2012 PLoS ONE 7(2): e25431
  120. Schully SD, Benedicto CB, Khoury MJ. How can we stimulate translational research in cancer genomics beyond bench to bedside? Genet Med. 2012 Jan;14(1):169-70.
  121. Scott RA, Chu AY, Grarup N, Manning AK, Hivert MF, Shungin D, Tönjes A, Yesupriya A, Barnes D, Bouatia-Naji N, Glazer NL, Jackson AU, Kutalik Z, Lagou V, Marek D, Rasmussen-Torvik LJ, Stringham HM, Tanaka T, Aadahl M, Arking DE, Bergmann S, Boerwinkle E, Bonnycastle LL, Bornstein SR, Brunner E, Bumpstead SJ, Brage S, Carlson OD, Chen H, Chen YD, Chines PS, Collins FS, Couper DJ, Dennison EM, Dowling NF, Egan JS, Ekelund U, Erdos MR, Forouhi NG, Fox CS, Goodarzi MO, Grässler J, Gustafsson S, Hallmans G, Hansen T, Hingorani A, Holloway JW, Hu FB, Isomaa B, Jameson KA, Johansson I, Jonsson A, Jørgensen T, Kivimaki M, Kovacs P, Kumari M, Kuusisto J, Laakso M, Lecoeur C, Lévy-Marchal C, Li G, Loos RJ, Lyssenko V, Marmot M, Marques-Vidal P, Morken MA, Müller G, North KE, Pankow JS, Payne F, Prokopenko I, Psaty BM, Renström F, Rice K, Rotter JI, Rybin D, Sandholt CH, Sayer AA, Shrader P, Schwarz PE, Siscovick DS, Stancáková A, Stumvoll M, Teslovich TM, Waeber G, Williams GH, Witte DR, Wood AR, Xie W, Boehnke M, Cooper C, Ferrucci L, Froguel P, Groop L, Kao WH, Vollenweider P, Walker M, Watanabe RM, Pedersen O, Meigs JB, Ingelsson E, Barroso I, Florez JC, Franks PW, Dupuis J, Wareham NJ, Langenberg C. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 2012 May;61(5):1291-6.
  122. Verma M, Khoury MJ, Ioannidis JP. Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling. Cancer Epidemiol Biomarkers Prev. 2012 Dec 14
  123. Yang Q, Bailey L, Clarke R, Flanders D, Liu T, Yesupriya A, Khoury MJ, Friedman J. Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults Am J Clin Nutr May 2012
  124. Zhang L, Yesupriya A, Hu DJ, Chang MH, Dowling NF, Ned RM, Udhayakumar V, Lindegren ML, Khudyakov Y. Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans. Hepatology. 2012 Apr;55(4):1008-18.
  125. Zimmern RL, Khoury MJ. The impact of genomics on public health practice: the case for change. Public Health Genomics. 2012;15(3-4):118-24.
  126. Zlot AI, Silvey K, Newell N, Leman R, Coates RJ. Family history of colorectal cancer: clinicians’ preventive recommendations and patient behavior. Prev Chronic Dis 2012 Jan;9:E21.  Top of Page

     

    2011
  127. Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. Genome Medicine: past, present and future.Genome Med. 2011 Jan 31;3(1):6.
  128. Atreya C, Nakhasi H, Mied P, Epstein J, Hughes J, Gwinn M, Kleinman S, Dodd R, Stramer S, Walderhaug M, Ganz P, Goodrich R, Tibbetts C, Asher D. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion. 2011 Aug;51(8):1855-71.
  129. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ. Awareness and Utilization of BRCA1/2 Testing Among U.S. Primary Care Physicians. Am J Prev Med. 2011 Jan;40(1):61-66.
  130. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time.Genet Med. 2011 May 9.
  131. Chang MH, Ned RM, Hong Y, Yesupriya A, Yang Q, Liu T, Janssens AC, Dowling NF. Race/Ethnic Variation in the Association of Lipid-Related Genetic Variants with Blood Lipids in the Adult U.S. Population. Circ Cardiovasc Genet. 2011 Oct;4(5):523-33.
  132. Chang MH, Valdez R, Ned RM, Liu T, Yang Q, Yesupriya A, Dowling NF, Meigs JB, Bowen MS, Khoury MJ. Influence of Familial Risk on Diabetes Risk-Reducing Behaviors Among U.S. Adults Without Diabetes. Diabetes Care.2011 Nov;34(11):2393-9.
  133. Coates R, Williams M, Melillo S, Gudgeon J. Genetic Testing for Lynch Syndrome in Individuals Newly Diagnosed with Colorectal Cancer to Reduce Morbidity and Mortality from Colorectal Cancer in Their Relatives. PLoS Curr. 2011 July 7.
  134. Dotson D, Khoury MJ. Public Health Genomics. Oxford Bibliographies Online
  135. Ferdinands J, Dension A, Dowling N, Jost H, Gwinn M, Liu L, Zaki S, Shay D. A Pilot Study of Host Genetic Variants Associated with Influenza-associated Deaths among Children and Young Adults Emerg Infect Dis. 2011 Dec;17(12):2294-302.
  136. Geneletti SG, Gallo V, Porta M, Khoury MJ, Vineis P. Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs [PDF 999.74 KB]. Emerging Themes in Epidemiology 2011, 8:5.
  137. Gwinn M, Grossniklaus DA, Yu W, Melillo S, Wulf A, Flome J, Dotson WD, Khoury MJ. Horizon scanning for new genomic tests. Genet Med. 2011 Feb;13(2):161-5.
  138. Ioannidis J, Khoury MJ. Improving Validation Practices in “Omics” Research. Science 2011 334(6060); 1230-1232.
  139. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O’Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest. 2011 Sep;41(9):1010-35.
  140. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O’Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol. 2011 Apr;26(4):313-37.
  141. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O’Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet. 2011 May;19(5):18 p preceding 494.
  142. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O’Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. J Clin Epidemiol. 2011 Aug;64(8):e1-e22.
  143. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Ann Intern Med. 2011 Mar 15;154(6):421-425.
  144. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ. 2011 Mar 16;342:d631.
  145. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Circ Cardiovasc Genet. 2011 Apr;4(2):206-9.
  146. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol. 2011 Apr;26(4):255-9.
  147. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Hum Genet. 2011 Aug;19(8):833-6.
  148. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest. 2011 Sep;41(9):1004-9.
  149. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Genet Med. 2011 May;13(5):453-6.
  150. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Genome Med. 2011 Mar 16;3(3):16.
  151. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. J Clin Epidemiol. 2011 Aug;64(8):843-7.
  152. Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ; for the GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. PLoS Med. 2011 Mar;8(3):e1000420.
  153. Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St Pierre J. Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med. 2011 Apr;40(4):486-93.
  154. Khoury MJ. Public health genomics: The end of the beginning. Genet Med. 2011 Mar;13(3):206-9.
  155. Khoury M, Clauser SB, Freedman AN, Gillanders EM, Glasgow RE, Klein WM, Schully SD. Population Sciences, Translational Research and the Promise of Genomics to Reduce the Burden of Cancer in the 21st Century. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2105-14.
  156. Khoury MJ, Gwinn M, Clyne M, Yu W. Genetic epidemiology with a capital E, ten years after. Genet Epidemiol 2011 Dec;35(8):845-52
  157. Khoury MJ, Gwinn M, Dotson WD, Bowen MS. Is there a need for PGxceptionalism? Genet Med. 2011 Jul 27.
  158. Moonesinghe R, Khoury MJ, Liu T, Janssens AC. Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models. Eur J Hum Genet. 2011 Feb;19(2):180-5.
  159. Ned RM, Sijbrands EJ. Cascade Screening for Familial Hypercholesterolemia (FH). PLoS Curr. 2011 May 23;3:RRN1238
  160. Ned RM., Melillo, S and Marrone M. Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test. PLoS Curr. 2011 March 8.
  161. Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational Research in Cancer Genetics: The Road Less Traveled. Public Health Genomics. 2011;14(1):1-8. Epub 2009 Dec 29.
  162. Schully SD, Yu W, McCallum V, Benedicto CB, Dong LM, Wulf A, Clyne M, Khoury MJ. Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet. 2011 Aug;19(8):928-30.
  163. Schulte In den B Auml Umen T., Muin J Khoury, Genome-based knowledge and public health: the vision of tomorrow and the challenge of today. Eur J Public Health. 2011 Feb;21(1):4-5.
  164. Valdez R, Coates RJ, St Pierre J, Grossniklaus D, Khoury MJ. Knowledge Gaps Remain in the Use of Family Health History in Public Health. Public Health Genomics. 2011;14(2):94-5. Epub 2010 May 12.
  165. Vassy JL, Shrader P, Yang Q, Liu T, Yesupriya A, Chang MH, Dowling NF, Ned RM, Dupuis J, Florez JC, Khoury MJ, Meigs JB. Genetic Associations with Metabolic Syndrome and Its Quantitative Traits by Race/Ethnicity in the United States. Metab Syndr Relat Disord. 2011 Dec;9(6):475-82.
  166. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB. Sodium and Potassium Intake and Mortality Among US Adults. Arch Intern Med. 2011;171(13):1183-1191.
  167. Yu W, Yesupriya A, Wulf A, Hindorff LA, Dowling N, Khoury MJ, Gwinn M. GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet. 2011 Oct;19(10):1095-9.

     Top of Page

     

    2010
  168. Acheson LS, Wang C, Zyzanski SJ, Lynn A, Ruffin MT 4th, Gramling R, Rubinstein WS, O’Neill SM, Nease DE Jr; Family Healthware Impact Trial (FHITr) Group. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med. 2010 Apr;12(4):212-8.
  169. Baron RC, Melillo S, Rimer BK, Coates RJ, Kerner J, Habarta N, Chattopadhyay S, Sabatino SA, Elder R, Leeks KJ and Task Force on Community Preventive Services. Intervention to Increase Recommendation and Delivery of Screening for Breast, Cervical, and Colorectal Cancers by Healthcare Providers: A Systematic Review of Provider Reminders. Am J Prev Med. 2010 Jan; 38(1):110-117.
  170. Bellcross C, W David Dotson. Tumor gene expression profiling in women with breast cancer: test category: prognostic. PLoS Curr. 2010 Sep 2.
  171. Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, Weiss LK, Liff JM, McDonald JA, Strom BL, Simon MS, Deapen D, Press MF, Burkman RT, Spirtas R, Ursin G. A Case-Control Study of Body Mass Index and Breast Cancer Risk in White and African-American Women. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1532-44. Epub 2010 May 25.
  172. Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, Szegda K, Dotson WD. Outcomes of interest in evidence-based evaluations of genetic tests. Genetics in Medicine Apr;12(4):228-35.
  173. Burke W, Burton H, Hall AE, Karmali M, Khoury MJ, Knoppers B, Meslin EM, Stanley F, Wright CF, Zimmern RL; Ickworth Group. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genet Med. 2010 Dec;12(12):785-91.
  174. Chang MH, Yesupriya A, Ned RM, Mueller PW, Dowling NF. Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey. BMC Med Genet. 2010 Apr 20;11:62.
  175. Dolan SM, Hollegaard MV, Merialdi M, Betran AP, Allen T, Abelow C, Nace J, Lin BK, Khoury MJ, Ioannidis JP, Bagade S, Zheng X, Dubin RA, Bertram L, Velez Edwards DR, Menon R. Synopsis of Preterm Birth Genetic Association Studies: The Preterm Birth Genetics Knowledge Base (PTBGene). Public Health Genomics. 2010 May 20.
  176. Evans JP, Burke W, Khoury M. The rules remain the same for genomic medicine: the case against “reverse genetic exceptionalism”. Genet Med. 2010 Jun;12(6):342-3.
  177. Fan AZ, Fang J, Yesupriya A, Chang MH, Kilmer G, House M, Hayes D, Ned R, Dowling NF, Mokdad AH. Gene polymorphisms in association with self-reported stroke in US adults. App Clin Gen 2010, 3:23-28.
  178. Fan AZ, Yesupriya A, Chang MH, House M, Fang J, Ned R, Hayes D, Dowling N, Mokdad A. Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. BMC Medical Genetics 2010 Jan;11(6).
  179. Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, Ballard-Barbash R, Doroshow JH, Minasian LM. Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation. J Natl Cancer Inst. 2010 Nov 17;102(22):1698-705.
  180. Ghosh A, Liu T, Khoury MJ, Valdez R. Family history of diabetes and prevalence of the metabolic syndrome in U.S. adults without diabetes: 6-year results from the National Health and Nutrition Examination Survey (1999-2004). Public Health Genomics. 2010;13(6):353-9. Epub 2009 Nov 26.
  181. Grosse SD, Kalman L, Khoury MJ. Evaluation of the validity and utility of genetic testing for rare diseases. Adv Exp Med Biol. 2010;686:115-31. Review.
  182. Grosse SD, Rogowski WH, Ross LF, Cornel MC, Dondorp WJ, Khoury MJ. Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and Ethics. Public Health Genomics. 2010;13(2):106-15. Epub 2009 Jun 29.
  183. Grossniklaus D. Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing: Test Category: Pharmacogenomic (Treatment). PLoS Curr. 2010 Sep 14.
  184. Gwinn M, W David Dotson, Khoury MJ. PLoS Currents: Evidence on Genomic Tests – At the Crossroads of Translation. PLoS Curr. 2010 Sep 2.
  185. Hawken SJ, Greenwood CM, Hudson TJ, Kustra R, McLaughlin J, Yang Q, Zanke BW, Little J. The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Hum Genet. 2010 May 1.
  186. Janssens AC, Khoury MJ. Assessment of improved prediction beyond traditional risk factors: when does a difference make a difference? Circ Cardiovasc Genet. 2010 Feb 1;3(1):3-5.
  187. Khoury MJ. Dealing with the evidence dilemma in genomics and personalized medicine.Clin Pharmacol Ther. 2010 Jun;87(6):635-8.
  188. Khoury MJ, Coates RJ, Evans JP. Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence. Genet Med. 2010 Nov;12(11):680-3.
  189. Khoury MJ, Feero WG, Valdez R. Family history and personal genomics as tools for improving health in an era of evidence-based medicine. Am J Prev Med. 2010 Aug;39(2):184-8.
  190. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010 Sep 1;172(5):517-24. Epub 2010 Aug 5.
  191. Khoury MJ, Reyes M, Gwinn M, Feero WG. A genetic test registry: bringing credible and actionable data together. Public Health Genomics. 2010;13(6):360-1. Epub 2009 Nov 26.
  192. Krieg EF Jr, Butler MA, Chang MH, Liu T, Yesupriya A, Dowling N, Lindegren ML; CDC/NCI NHANES III Genomics Working Group. Lead and cognitive function in VDR genotypes in the third National Health and Nutrition Examination Survey. Neurotoxicol Teratol. 2010 Mar-Apr;32(2):262-72. Epub 2009 Dec 18.
  193. Li J, Coates RJ, Gwinn M, Khoury MJ. Steroid 5-{alpha}-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review. Am J Epidemiol. 2010 Jan 1;171(1):1-13. Epub 2009 Nov 13.
  194. Lill CM, Schjeide BM, Roehr JT, Zauft U, Allen NC, Zipp F, McQueen MB, Kavvoura FK, Ioannidis JP, Khoury MJ, Tanzi RE, Bertram L. Correspondence to Sand et Al. “Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia”. Biol Psychiatry. 2010 Apr 1;67(7):e45-8.
  195. McBride CM, Bowen D, Brody LC, Condit CM, Croyle RT, Gwinn M, Khoury MJ, Koehly LM, Korf BR, Marteau TM, McLeroy K, Patrick K, Valente TW. Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med. 2010 May;38(5):556-65.
  196. Moonesinghe R, Liu T, Khoury MJ. Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases. Eur J Hum Genet. 2010 Apr;18(4):485-9. Epub 2009 Nov 25.
  197. Moonesinghe R, Yesupriya A, Chang MH, Dowling NF, Khoury MJ; Alastair J. Scott for the CDC/NCI NHANES III Genomics Working Group. A Hardy-Weinberg Equilibrium Test for Analyzing Population Genetic Surveys With Complex Sample Designs. Am J Epidemiol. 2010 Apr 15;171(8):932-41.
  198. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010 Feb;12(2):93-104.
  199. Ned, Renée M. Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availability. PLoS Curr. 2010 Sep 20.
  200. Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, Chang MH, Dowling NF. Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. BMC Med Genet. 2010 Nov 5;11:155.
  201. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA. 2010 Feb 17;303(7):648-56.
  202. Palomaki GE, Melillo S, Neveux L, Douglas MP, Dotson WD, Janssens AC, Balkite EA, Bradley LA. Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies-A targeted evidence-based review. Genet Med. 2010 Dec;12(12):772-84.
  203. Ransohoff DF, Khoury MJ. Personal genomics: information can be harmful. Eur J Clin Invest. 2010 Jan;40(1):64-8.
  204. Scinicariello F, Yesupriya A, Chang MH, Fowler BA. Modification by ALAD of the Association between Blood Lead and Blood Pressure in the U.S. Population: Results from the Third National Health and Nutrition Examination Survey. Environ Health Perspect. 2010 Feb;118(2):259-64.
  205. Tangka FK, O’Hara B, Gardner JG, Turner J, Royalty J, Shaw K, Sabatino S, Hall IJ, Coates RJ. Meeting the cervical cancer screening needs of underserved women: The National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control. 2010 Jul;21(7):1081-90.
  206. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ. Family History in Public Health Practice: A Genomic Tool for Disease Prevention and Health Promotion. Annu Rev Public Health. 2010 Apr 21;31:69-87 1 p following 87.
  207. Wang SS, Beaty TH, Khoury MJ. Genetic epidemiology. In Speicher MR, Antonarakis SE, Motulsky AG (eds). Vogel and Motulsky’s Human Genetics: Problems and Approaches. Fourth Edition, Springer, Heidelberg 2010: pp 617-634.
  208. Waltenburg R, Kobrynski L, Reyes M, Bowen S, Khoury MJ. Primary immunodeficiency diseases: Practice among primary care providers and awareness among the general public, United States, 2008. Genet Med. 2010 Dec;12(12):792-800.
  209. Yang Q, Cogswell ME, Hamner HC, Carriquiry A, Bailey LB, Pfeiffer CM, Berry RJ. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr. 2010 Jan;91(1):64-72. Epub 2009 Oct 14.
  210. Yang Q, Liu T, Shrader P, Yesupriya A, Chang MH, Dowling NF, Ned RM, Dupuis J, Florez JC; the MAGIC Investigators, Khoury MJ, Meigs JB. Racial/Ethnic Differences in Association of Fasting Glucose-Associated Genomic Loci with Fasting Glucose, HOMA-B and Impaired Fasting Glucose in U.S. Adult Population. Diabetes Care. 2010 Nov;33(11):2370-7.
  211. Yang Q, Liu T, Valdez R, Moonesinghe R, Khoury MJ. Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol. 2010 May 15;171(10):1079-89. Epub 2010 Apr 25.
  212. Yu W, Clyne M, Khoury MJ, Gwinn M. Phenopedia and Genopedia: Disease-centered and Gene-centered Views of the Evolving Knowledge of Human Genetic Associations. Bioinformatics. 2010 Jan 1;26(1):145-6. Epub 2009 Oct 27.
  213. Yu W, Tiebin Liu, Rodolfo Valdez, Marta Gwinn and Muin J Khoury. Application of Support Vector Machine Modeling for Prediction of Common Diseases: The Case of Diabetes and Pre-diabetes. BMC Medical Informatics and Decision Making 2010, 10:16.
  214. Zhang L, Prather D, Eng JV, Crawford S, Kariuki S, ter Kuile F, Terlouw D, Nahlen B, Lal AA, Slutsker L, Udhayakumar V, Shi YP. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya. Malar J. 2010 Mar 29;9:87.
  215. Zlot AI, Valdez R, Han Y, Silvey K, Leman RF. Influence of Family History of Cardiovascular Disease on Clinicians’ Preventive Recommendations and Subsequent Adherence of Patients without Cardiovascular Disease. Public Health Genomics. 2010 Mar 17.

Publications prior to 2010

 Top of Page

TOP